Business Wire

CO-NEWMONT-CORP

14.4.2022 17:02:12 CEST | Business Wire | Press release

Share
Newmont Publishes 2021 Sustainability Report

Today, Newmont Corporation (NYSE: NEM, TSX: NGT) launched its 2021 Sustainability Report as part of its suite of reports on the Company’s environmental, social and governance (ESG) practices in key areas that include health, safety and security, human rights, the environment, social acceptance, governance, and inclusion and diversity.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220414005599/en/

“Newmont has a long tradition of setting and transparently reporting against public targets. With this report, we offer stakeholders a clear and comprehensive understanding of our most material sustainability topics,” said Tom Palmer, Newmont President and CEO. “As the world’s leading gold company, our ESG practices are woven into the fabric of our company as we work to deliver on our purpose: to create value and improve lives through sustainable and responsible mining.”

Highlights of Newmont’s 2021 Sustainability Report:

  • Commitment to health and safety: Achieved zero work-related fatalities for the third year in a row. Further embedded our Fatality Risk Management program with a focus on verifying the critical controls that prevent fatalities and coaching frontline leaders to provide visible, felt leadership.
  • Response to COVID-19: Continued to put the health, safety and wellbeing of our workforce and host communities at the heart of every decision the Company made. Newmont strongly supported COVID-19 vaccines as they became available and adopted the position of requiring all employees and third-party workers to be fully vaccinated. With contributions through Newmont’s Global Community Support Fund, the Company supported COVID-19 testing facilities, vaccine awareness campaigns and vaccine rollouts in areas near our operations.
  • Sustainability-linked financial performance: Established the industry’s first sustainability-linked bond, holding Newmont to account for meeting our 2030 emissions reductions targets and to achieve gender parity in senior leadership roles by 2030. This represents the next step in aligning our business to our commitments and values by linking the interest rate payout to our performance on key ESG priorities.
  • Value sharing: Newmont played an important role in creating economic value in host communities and jurisdictions, contributing $10.8 billion to its workforce, host communities and jurisdictions through wages and benefits, operating costs, capital spend, royalties and taxes. This includes spending $1.4 billion with local and Indigenous suppliers, $21.9 million in community investments and providing ongoing opportunities for local and Indigenous employment, along with an additional $3.5 million from Newmont’s Global Community Support Fund.

Newmont’s sustainability efforts continue to be recognized by several leading independent organizations:

  • Recognized as a leading gold miner for the seventh consecutive year in the Dow Jones Sustainability Index (DJSI) while continuing to be ranked as the top mining company on FORTUNE’s list of the World’s Most Admired Companies;
  • Earned a rating of “AA” from MSCI, putting Newmont in the top quartile for precious metals and mining;
  • Listed as sixth overall and the top mining company in 3BL’s 100 Best Corporate Citizens;
  • Included in Bloomberg’s Gender-Equality Index (GEI) for Newmont’s efforts to advance women in the workplace for the fourth successive year;
  • Named to the JUST 100 as one of America’s most JUST companies by JUST Capital and CNBC, included in the JUST 100 and named Industry Leader for 2022; and
  • One of the most transparent companies in the S&P 500, according to Bloomberg’s ESG Disclosure Score.

Newmont’s 2021 Sustainability Report is written in accordance with the GRI 2016 Universal Standards Core option, the GRI Mining and Metals Sector Supplement, the Sustainability Accounting Standards Board (SASB) Metals and Mining standards and is externally assured by an independent third-party. Additionally, Newmont’s sustainability report aligns with ICMM’s Mining Principles’ Performance Expectations and the World Gold Council’s Responsible Gold Mining Principles.

The full 2021 Sustainability Report, along with the ESG data tables and comprehensive GRI and SASB content indices, is available for download on Newmont’s website .

About Newmont

Newmont is the world’s leading gold company and a producer of copper, silver, zinc and lead. The Company’s world-class portfolio of assets, prospects and talent is anchored in favorable mining jurisdictions in North America, South America, Australia and Africa. Newmont is the only gold producer listed in the S&P 500 Index and is widely recognized for its principled environmental, social and governance practices. The Company is an industry leader in value creation, supported by robust safety standards, superior execution and technical expertise. Newmont was founded in 1921 and has been publicly traded since 1925.

At Newmont, our purpose is to create value and improve lives through sustainable and responsible mining. To learn more about Newmont’s sustainability strategy and initiatives, go to www.newmont.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye